. | Round 1 (n = 54) . | Round 2 (n = 49) . | ||
---|---|---|---|---|
Gender | ||||
Female | 31 | 57% | 30 | 61% |
Male | 22 | 41% | 18 | 37% |
Other | 1 | 2% | 1 | 2% |
Profession/background | ||||
Brain Cancer Carer | 6 | 11% | 4 | 8% |
Brain Cancer Patient | 4 | 7% | 3 | 6% |
Medical Oncologist | 9 | 17% | 9 | 18% |
Neuro-Oncologist | 2 | 4% | 2 | 4% |
Neuropathologist | 3 | 6% | 3 | 6% |
Neurosurgeon | 6 | 11% | 4 | 8% |
Nurse Consultant | 1 | 2% | 1 | 2% |
Other | 7 | 13% | 7 | 14% |
Palliative Care Clinician | 2 | 4% | 2 | 4% |
Radiation Oncologist | 5 | 9% | 5 | 10% |
Radiologist | 1 | 2% | 1 | 2% |
Rehabilitation Clinician | 1 | 2% | 1 | 2% |
Research/Public Health | 5 | 9% | 5 | 10% |
Social Worker | 1 | 2% | 1 | 2% |
Trainee | 1 | 2% | 1 | 2% |
Geographic location | ||||
Metropolitan | 48 | 89% | 45 | 92% |
Regional | 6 | 11% | 4 | 8% |
Membershipa | ||||
Brain Tumour Alliance Australia (BTAA) | — | 23% | — | 22% |
Cooperative Trials Group for Neuro-Oncology (COGNO) | — | 29% | — | 29% |
Clinical Oncology Society of Australia (COSA) | — | 11% | — | 13% |
Neurosurgical Society of Australasia (NSA) | — | 7% | — | 5% |
Royal College of Pathologists of Australasia (RCPA) | — | 4% | — | 3% |
Trans Tasman Radiation Oncology Group (TROG) | — | 7% | — | 8% |
Other | — | 17% | — | 18% |
Not a member of a professional society or consumer group | — | 1% | — | 1% |
. | Round 1 (n = 54) . | Round 2 (n = 49) . | ||
---|---|---|---|---|
Gender | ||||
Female | 31 | 57% | 30 | 61% |
Male | 22 | 41% | 18 | 37% |
Other | 1 | 2% | 1 | 2% |
Profession/background | ||||
Brain Cancer Carer | 6 | 11% | 4 | 8% |
Brain Cancer Patient | 4 | 7% | 3 | 6% |
Medical Oncologist | 9 | 17% | 9 | 18% |
Neuro-Oncologist | 2 | 4% | 2 | 4% |
Neuropathologist | 3 | 6% | 3 | 6% |
Neurosurgeon | 6 | 11% | 4 | 8% |
Nurse Consultant | 1 | 2% | 1 | 2% |
Other | 7 | 13% | 7 | 14% |
Palliative Care Clinician | 2 | 4% | 2 | 4% |
Radiation Oncologist | 5 | 9% | 5 | 10% |
Radiologist | 1 | 2% | 1 | 2% |
Rehabilitation Clinician | 1 | 2% | 1 | 2% |
Research/Public Health | 5 | 9% | 5 | 10% |
Social Worker | 1 | 2% | 1 | 2% |
Trainee | 1 | 2% | 1 | 2% |
Geographic location | ||||
Metropolitan | 48 | 89% | 45 | 92% |
Regional | 6 | 11% | 4 | 8% |
Membershipa | ||||
Brain Tumour Alliance Australia (BTAA) | — | 23% | — | 22% |
Cooperative Trials Group for Neuro-Oncology (COGNO) | — | 29% | — | 29% |
Clinical Oncology Society of Australia (COSA) | — | 11% | — | 13% |
Neurosurgical Society of Australasia (NSA) | — | 7% | — | 5% |
Royal College of Pathologists of Australasia (RCPA) | — | 4% | — | 3% |
Trans Tasman Radiation Oncology Group (TROG) | — | 7% | — | 8% |
Other | — | 17% | — | 18% |
Not a member of a professional society or consumer group | — | 1% | — | 1% |
aPanelist may have more than one membership.
. | Round 1 (n = 54) . | Round 2 (n = 49) . | ||
---|---|---|---|---|
Gender | ||||
Female | 31 | 57% | 30 | 61% |
Male | 22 | 41% | 18 | 37% |
Other | 1 | 2% | 1 | 2% |
Profession/background | ||||
Brain Cancer Carer | 6 | 11% | 4 | 8% |
Brain Cancer Patient | 4 | 7% | 3 | 6% |
Medical Oncologist | 9 | 17% | 9 | 18% |
Neuro-Oncologist | 2 | 4% | 2 | 4% |
Neuropathologist | 3 | 6% | 3 | 6% |
Neurosurgeon | 6 | 11% | 4 | 8% |
Nurse Consultant | 1 | 2% | 1 | 2% |
Other | 7 | 13% | 7 | 14% |
Palliative Care Clinician | 2 | 4% | 2 | 4% |
Radiation Oncologist | 5 | 9% | 5 | 10% |
Radiologist | 1 | 2% | 1 | 2% |
Rehabilitation Clinician | 1 | 2% | 1 | 2% |
Research/Public Health | 5 | 9% | 5 | 10% |
Social Worker | 1 | 2% | 1 | 2% |
Trainee | 1 | 2% | 1 | 2% |
Geographic location | ||||
Metropolitan | 48 | 89% | 45 | 92% |
Regional | 6 | 11% | 4 | 8% |
Membershipa | ||||
Brain Tumour Alliance Australia (BTAA) | — | 23% | — | 22% |
Cooperative Trials Group for Neuro-Oncology (COGNO) | — | 29% | — | 29% |
Clinical Oncology Society of Australia (COSA) | — | 11% | — | 13% |
Neurosurgical Society of Australasia (NSA) | — | 7% | — | 5% |
Royal College of Pathologists of Australasia (RCPA) | — | 4% | — | 3% |
Trans Tasman Radiation Oncology Group (TROG) | — | 7% | — | 8% |
Other | — | 17% | — | 18% |
Not a member of a professional society or consumer group | — | 1% | — | 1% |
. | Round 1 (n = 54) . | Round 2 (n = 49) . | ||
---|---|---|---|---|
Gender | ||||
Female | 31 | 57% | 30 | 61% |
Male | 22 | 41% | 18 | 37% |
Other | 1 | 2% | 1 | 2% |
Profession/background | ||||
Brain Cancer Carer | 6 | 11% | 4 | 8% |
Brain Cancer Patient | 4 | 7% | 3 | 6% |
Medical Oncologist | 9 | 17% | 9 | 18% |
Neuro-Oncologist | 2 | 4% | 2 | 4% |
Neuropathologist | 3 | 6% | 3 | 6% |
Neurosurgeon | 6 | 11% | 4 | 8% |
Nurse Consultant | 1 | 2% | 1 | 2% |
Other | 7 | 13% | 7 | 14% |
Palliative Care Clinician | 2 | 4% | 2 | 4% |
Radiation Oncologist | 5 | 9% | 5 | 10% |
Radiologist | 1 | 2% | 1 | 2% |
Rehabilitation Clinician | 1 | 2% | 1 | 2% |
Research/Public Health | 5 | 9% | 5 | 10% |
Social Worker | 1 | 2% | 1 | 2% |
Trainee | 1 | 2% | 1 | 2% |
Geographic location | ||||
Metropolitan | 48 | 89% | 45 | 92% |
Regional | 6 | 11% | 4 | 8% |
Membershipa | ||||
Brain Tumour Alliance Australia (BTAA) | — | 23% | — | 22% |
Cooperative Trials Group for Neuro-Oncology (COGNO) | — | 29% | — | 29% |
Clinical Oncology Society of Australia (COSA) | — | 11% | — | 13% |
Neurosurgical Society of Australasia (NSA) | — | 7% | — | 5% |
Royal College of Pathologists of Australasia (RCPA) | — | 4% | — | 3% |
Trans Tasman Radiation Oncology Group (TROG) | — | 7% | — | 8% |
Other | — | 17% | — | 18% |
Not a member of a professional society or consumer group | — | 1% | — | 1% |
aPanelist may have more than one membership.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.